ARCHIVES

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

Modeling Will Be Used For Other Populations

November 26, 2010

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005